Assessment of tissue levels of miR-146a and proinflammatory cytokines in experimental cerebral toxoplasmosis following atovaquone and clindamycin treatment: An …
Background Despite recent advances for treating cerebral toxoplasmosis (CT), monitoring
the parasite burden and treatment response is still challenging. miRNAs are small non …
the parasite burden and treatment response is still challenging. miRNAs are small non …
Assessment of tissue levels of miR-146a and proinflammatory cytokines in experimental cerebral toxoplasmosis following atovaquone and clindamycin treatment: An …
N Zouei, A Dalimi, M Pirestani… - Microbial Pathogenesis, 2023 - europepmc.org
Background Despite recent advances for treating cerebral toxoplasmosis (CT), monitoring
the parasite burden and treatment response is still challenging. miRNAs are small non …
the parasite burden and treatment response is still challenging. miRNAs are small non …
Assessment of tissue levels of miR-146a and proinflammatory cytokines in experimental cerebral toxoplasmosis following atovaquone and clindamycin treatment: An …
N Zouei, A Dalimi, M Pirestani… - Microbial … - pubmed.ncbi.nlm.nih.gov
Background Despite recent advances for treating cerebral toxoplasmosis (CT), monitoring
the parasite burden and treatment response is still challenging. miRNAs are small non …
the parasite burden and treatment response is still challenging. miRNAs are small non …